Human lysosomal .beta.-galactosidase-cathepsin A complex: Definition of the .beta.-galactosidase-binding interface on cathepsin A
Abstract
Human lysosomal beta-galactosidase is organized as a 680-kDa complex with cathepsin A (also named carboxypeptidase L and protective protein), which is necessary to protect beta-galactosidase from intralysosomal proteolysis. To understand the molecular mechanism of beta-galactosidase protection by cathepsin A, we defined the structural organization of their complex including the beta-galactosidase-binding interface on cathepsin A. Radiation inactivation analysis suggested the existence of a 168-kDa structural subunit of the complex containing both beta-galactosidase and cathepsin A. Chemical cross-linking of the complex confirmed the existence of this subunit and showed that it is composed of one cathepsin A dimer and one beta-galactosidase monomer. The modeling of the cathepsin A dimer tertiary structure based on atomic coordinates of a wheat carboxypeptidase suggested a putative beta-galactosidase-binding cavity formed by the association of two cathepsin A monomers. According to this model two exposed loops of cathepsin A bordering the cavity were chosen as part of a putative beta-galactosidase-binding interface. Synthetic peptides corresponding to these loops were found both to dissociate the complex and to inhibit its in vitro reconstitution from purified cathepsin A and beta-galactosidase. The defined location of the GAL monomer in the complex with 35% of its surface covered by the CathA dimer may explain the stabilizing effect of CathA on GAL in lysosome.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the absence of functional PPCA, NEU1 is retained in the endosomal compartment while the pool of β-GAL reaching lysosomes is rapidly degraded; formation of the PPCA/NEU1/β-GAL complex has a reciprocal advantage for the three enzymes, which acquire active and stable conformation in lysosomes.
“In absence of functional PPCA, NEU1 is retained in the endosomal compartment while the pool of β-GAL reaching the lysosomes is rapidly degraded 36.”
From Galactosialidosis: historic aspects and overview of investigated and emerging treatment options (2017) · cites this paper as [41]
Cited by
Sorted by citations
Galactosialidosis: historic aspects and overview of investigated and emerging treatment options
Annunziata, I., & d’Azzo, A. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1266933 · Cited by 50 · see citing works
- Authors
- Pshezhetsky, A. V., Elsliger, M.-A., Vinogradova, M. V., & Potier, M.
- Affiliations
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1995-02-28
- Volume
- 34
- Issue
- 8
- Pages
- 2431-2440
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W1989427843
- Cited by
- 26
- References
- 0
- Citations by year
- 2021: 1 · 2020: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2012: 2
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council Canada
- Topics
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Physical Sciences › Materials Science › Materials Chemistry › Enzyme Structure and Function
- Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
- Keywords
- lysosomal beta-galactosidase, cathepsin A, radiation inactivation, crosslinking, peptide fragmentation, protein-protein interaction
- MeSH terms
- Amino Acid Sequence, beta-Galactosidase, Binding Sites, Carboxypeptidases, Cross-Linking Reagents, Humans, Kinetics, Lysosomes, Models, Molecular, Molecular Sequence Data, Peptide Fragments, Protein Conformation, Cathepsin A, Macromolecular Substances, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review